3'-Hydroxy-biphenyl-3-carbaldehyde

Catalog No.: 
ACWHBF150
CAS No.: 
400745-17-7
Molecular Formula: 
C13H10O2
Molecular Weight: 
198.22
3'-Hydroxy-biphenyl-3-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg96%$1001.001 week1 week
1g96%$1292.00In stock1 week

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3'-Hydroxy-biphenyl-3-carbaldehyde
IUPAC Name3'-hydroxy-[1,1'-biphenyl]-3-carbaldehyde
MDL No.MFCD04117377
Molecular FormulaC13H10O2
Molecular Weight198.22
SMILESO=CC1=CC(C2=CC=CC(O)=C2)=CC=C1
InChI KeyMFZQXRUPOBECBS-UHFFFAOYSA-N
Synonym3-(3-Hydroxyphenyl)benzaldehyde;3-(3-ForMylphenyl)phenol;[1,1'-Biphenyl]-3-carboxaldehyde, 3'-hydroxy-;3'-Hydroxy[1,1'-biphenyl]-3-carboxaldehyde;3'-Hydroxy[1,1'-biphenyl]-3-carboxaldehyde
CAS No.400745-17-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312+P330-P501

Synthetic Route by SureRoute

1. ACWHBF150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXZFJ430 route compound structure diagram
    ACXZFJ43087199-16-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWHBF150 route product structure diagram
    ACWHBF150400745-17-7In Stock
Inquiry

2. ACWHBF150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUEAK970 route compound structure diagram
    ACUEAK9703132-99-8In Stock
  2. Plus
  3. ACLDAW054 route compound structure diagram
    ACLDAW05487199-18-6In Stock
  4. Then
  5. ACWHBF150 route product structure diagram
    ACWHBF150400745-17-7In Stock
Inquiry

3. ACWHBF150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWHBF150 route product structure diagram
    ACWHBF150400745-17-7In Stock
Inquiry

Comments (0)